SOD1 and amyotrophic lateral sclerosis: Mistakes in this area can be significant, for example therapies developed for the SOD1-mouse model of ALS have largely failed to translate because SOD1-ALS is not representative of the majority of ALS patients having a distinct molecular basis and neuropathology (26).